Compare KITT & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KITT | BMRA |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 5.0M |
| IPO Year | 2021 | 1995 |
| Metric | KITT | BMRA |
|---|---|---|
| Price | $0.65 | $2.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 483.2K | 183.6K |
| Earning Date | 04-16-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.55 | 39.81 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,434,959.00 | $4,453,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 33.10 | N/A |
| 52 Week Low | $0.39 | $1.45 |
| 52 Week High | $4.48 | $3.21 |
| Indicator | KITT | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 32.48 | 68.32 |
| Support Level | $0.46 | $2.05 |
| Resistance Level | $1.03 | $2.26 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 2.39 | 81.38 |
Nauticus Robotics Inc is a technology-driven company specializing in the development of fully electric autonomous robotic solutions for subsea applications. Its portfolio includes autonomous underwater vehicles (AUVs), electric robotic manipulators, a platform-agnostic robotic operating system, and related engineering, consulting and prototype services. The Company's solutions enable autonomous operations for both commercial and defense sectors, with alignment to offshore energy and national security interests. Its addressable markets include upstream, midstream and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research and subsea mining, with current focus on oil and gas operations and defense applications.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.